Morgan Stanley Bio Techne Corp Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Bio Techne Corp stock. As of the latest transaction made, Morgan Stanley holds 4,190,278 shares of TECH stock, worth $323 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,190,278
Previous 4,088,095
2.5%
Holding current value
$323 Million
Previous $315 Million
6.49%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding TECH
# of Institutions
581Shares Held
154MCall Options Held
180KPut Options Held
189K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.41 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY17.7MShares$1.37 Billion0.03% of portfolio
-
State Street Corp Boston, MA6.37MShares$492 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.75MShares$444 Million0.05% of portfolio
-
Bamco Inc New York, NY5MShares$386 Million0.95% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $3.03B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...